![Kumar Dhanasekharan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kumar Dhanasekharan is currently the Senior Vice President-Technical Operations at Renovacor, Inc. Previously, he worked as the Vice President-Technical Operations at SwanBio Therapeutics, Inc. He completed his undergraduate degree at the Indian Institute of Technology Madras and his doctorate at Rutgers University, Camden.
| Sociétés | Poste | Début |
|---|---|---|
| RENOVACOR, INC. | Directeur Technique/Scientifique/R&D | 04/10/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops treatments for neurological disorders | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Indian Institute of Technology Madras
 Indian Institute of Technology Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers University, Camden
 Rutgers University, Camden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage gene therapy company that develops treatments for neurological disorders | Health Technology |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
